EAT is up +49.38%% since April’24 pick View All Top Buy Picks
Currently predicting for Mon, 1 Jul 2024

Trading levels for NYR.AX

Fibonacci Support & Resistance Levels

Level Price
R3 0.0603 2.26%
R2 0.0596 0.96%
R1 0.0591 0.165%
Price 0.0590
S1 0.0576 -2.42%
S2 0.0571 -3.22%
S3 0.0563 -4.52%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0700 18.64%
R2 0.0660 11.86%
R1 0.0650 10.17%
Price 0.0590
S1 0.0580 -1.69%
S2 0.0570 -3.39%
S3 0.0560 -5.08%

NYR.AX Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Nyrada Inc.

Nyrada. Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; NYR-BI01, a neuroprotectant drug, to reduce the disability in patients with is... NYR.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT